» Articles » PMID: 37463570

Obesity Paradox in Lung Diseases: What Explains It?

Overview
Journal Obes Facts
Publisher Karger
Specialty Endocrinology
Date 2023 Jul 18
PMID 37463570
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity is a globally increasing health problem that impacts multiple organ systems and a potentially modifiable risk factor for many diseases. Obesity has a significant impact on lung function and is strongly linked to the pathophysiology that contributes to lung diseases. On the other hand, reports have emerged that obesity is associated with a better prognosis than for normal weight individuals in some lung diseases, including pneumonia, acute lung injury/acute respiratory distress syndrome, chronic obstructive pulmonary disease, and lung cancer. The lesser mortality and better prognosis in patients with obesity is known as obesity paradox. While obesity paradox is both recognized and disputed in epidemiological studies, recent research has suggested possible mechanisms.

Summary: In this review, we attempted to explain and summarize these factors and mechanisms, including immune response, pulmonary fibrosis, lung function, microbiota, fat and muscle reserves, which are significantly altered by obesity and may contribute to the obesity paradox in lung diseases. We also discuss contrary literature that attributes the "obesity paradox" to confounding.

Key Messages: The review will illustrate the possible role of obesity in the prognosis or course of lung diseases, leading to a better understanding of the obesity paradox and provide hints for further basic and clinical research in lung diseases.

Citing Articles

Malnutrition and Obesity in Patients with COPD Exacerbation, Insights from the National Inpatient Sample.

El Labban M, El-Zibaoui R, Usama S, Niaz F, Cohen A, Krastev P Open Respir Med J. 2024; 18:e18743064322829.

PMID: 39450126 PMC: 11499682. DOI: 10.2174/0118743064322829240801094830.


Association between body roundness index and risk of osteoarthritis: a cross-sectional study.

Wang X, Guo Z, Wang M, Xiang C Lipids Health Dis. 2024; 23(1):334.

PMID: 39402634 PMC: 11472493. DOI: 10.1186/s12944-024-02324-5.


Tamping Down the Fire: Taming Pyroptosis through RNA Methylation in Acute Lung Injury.

Shin K, Hamanaka R Am J Respir Cell Mol Biol. 2024; 70(5):331-333.

PMID: 38353587 PMC: 11109585. DOI: 10.1165/rcmb.2024-0001ED.

References
1.
Nitsche L, Mukherjee S, Cheruvu K, Krabak C, Rachala R, Ratnakaram K . Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies. Cancers (Basel). 2022; 14(6). PMC: 8946288. DOI: 10.3390/cancers14061440. View

2.
Zulueta J, Wisnivesky J, Henschke C, Yip R, Farooqi A, McCauley D . Emphysema scores predict death from COPD and lung cancer. Chest. 2011; 141(5):1216-1223. PMC: 3415146. DOI: 10.1378/chest.11-0101. View

3.
Cecere L, Littman A, Slatore C, Udris E, Bryson C, Boyko E . Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD. 2011; 8(4):275-84. PMC: 3169653. DOI: 10.3109/15412555.2011.586660. View

4.
Machado F, Spruit M, Groenen M, Houben-Wilke S, van Melick P, Hernandes N . Frequency and functional translation of low muscle mass in overweight and obese patients with COPD. Respir Res. 2021; 22(1):93. PMC: 7993483. DOI: 10.1186/s12931-021-01689-w. View

5.
Phung D, Wang Z . Risk of pneumonia in relation to body mass index in Australian Aboriginal people. Epidemiol Infect. 2013; 141(12):2497-502. PMC: 9151361. DOI: 10.1017/S0950268813000605. View